Arabian International Healthcare Holding Company (9530.SR)
SAR 43.0
(1.53%)
SAR 43.0
(1.53%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 806.92 Million | 642.7 Million | 618.53 Million | 818.68 Million | 697.03 Million |
| Cost of Revenue | 630.08 Million | 488.5 Million | 475.02 Million | 620.3 Million | 525.68 Million |
| Gross Profit | 176.84 Million | 154.2 Million | 143.51 Million | 198.37 Million | 171.34 Million |
| Operating Expenses | 130.12 Million | 109.1 Million | 90.96 Million | 100.06 Million | 90.47 Million |
| Selling, General and Administrative Expenses | 130.12 Million | 109.1 Million | 18.95 Million | 20.16 Million | 18.17 Million |
| Research and Development Expenses | - | - | - | - | - |
| Other Expenses | - | 2.82 Million | 72 Million | 79.9 Million | 72.29 Million |
| Cost and Expenses | 766.85 Million | 597.6 Million | 565.98 Million | 720.36 Million | 616.15 Million |
| Operating Income | 40.06 Million | 45.1 Million | 74.57 Million | 110.22 Million | 82.34 Million |
| Interest Expense | 39.86 Million | 18.51 Million | 12.99 Million | 22.04 Million | 25.61 Million |
| Income Tax Expense | 11.57 Million | 10.9 Million | 11.42 Million | 24 Million | 15.6 Million |
| Earnings before Tax | 55.95 Million | 34.5 Million | 93.73 Million | 119.79 Million | 56.72 Million |
| Net Income | 38.08 Million | 20.47 Million | 82.31 Million | 95.79 Million | 41.12 Million |
| Earnings Per Share Basic | 1.92 | 1.29 | 4.12 | 4.79 | 2.06 |
| Earnings Per Share Diluted | 1.92 | 1.02 | 4.12 | 4.79 | 2.06 |
| Weighted Average Shares Outstanding | 19.79 Million | 19.97 Million | 20 Million | 20 Million | 20 Million |
| Weighted Average Shares Outstanding (Diluted) | 19.79 Million | 19.97 Million | 20 Million | 20 Million | 20 Million |
| Gross Margin | 0.22 | 0.24 | 0.23 | 0.24 | 0.25 |
| EBIT Margin | 0.14 | 0.11 | 0.13 | 0.14 | 0.17 |
| Profit Margin | 0.05 | 0.03 | 0.13 | 0.12 | 0.06 |
| EBITDA | 111.1 Million | 65.11 Million | 106.44 Million | 147.64 Million | 90.23 Million |
| Earnings Before Tax Margin | 0.05 | 0.07 | 0.12 | 0.13 | 0.12 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 137.04 Million | 137.04 Million | 490.96 Million | 806.92 Million | 245.48 Million | 315.96 Million |
| Cost of Revenue | 106.31 Million | 106.31 Million | 369.64 Million | 630.08 Million | 181.91 Million | 257.09 Million |
| Gross Profit | 30.73 Million | 30.73 Million | 121.31 Million | 176.84 Million | 63.56 Million | 58.86 Million |
| Operating Expenses | 49.07 Million | 49.07 Million | 71.86 Million | 130.12 Million | 20.61 Million | 61.58 Million |
| Selling, General and Administrative Expenses | 38.97 Million | 38.97 Million | 71.86 Million | - | 38.84 Million | 61.58 Million |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | 10.1 Million | 10.1 Million | - | 1.47 Million | - | - |
| Cost and Expenses | 155.38 Million | 155.38 Million | 441.51 Million | 760.2 Million | 202.52 Million | 318.68 Million |
| Operating Income | -18.34 Million | -18.34 Million | 49.44 Million | 46.71 Million | 29.46 Million | -2.72 Million |
| Interest Expense | 18.1 Million | - | 20.69 Million | 36.16 Million | - | 15.9 Million |
| Income Tax Expense | 3 Million | 3 Million | 6.7 Million | 11.57 Million | 3.35 Million | 4.86 Million |
| Earnings before Tax | -13.57 Million | -13.57 Million | 70.82 Million | 55.95 Million | 34.27 Million | -14.87 Million |
| Net Income | -15.9 Million | -15.9 Million | 60.88 Million | 38.08 Million | 30.44 Million | -22.8 Million |
| Earnings Per Share Basic | -0.80 | -0.80 | 3.08 | - | 1.54 | -1.15 |
| Earnings Per Share Diluted | -0.80 | -0.80 | 3.08 | - | 1.54 | -1.15 |
| Weighted Average Shares Outstanding | 19.79 Million | 19.79 Million | 19.79 Million | 19.79 Million | 19.79 Million | 19.79 Million |
| Weighted Average Shares Outstanding (Diluted) | 19.79 Million | 19.79 Million | 19.79 Million | 19.79 Million | 19.79 Million | 19.79 Million |
| Gross Margin | 0.22 | 0.22 | 0.25 | 0.22 | 0.26 | 0.19 |
| EBIT Margin | -0.02 | -0.02 | 0.12 | - | 0.13 | 0.01 |
| Profit Margin | -0.12 | -0.12 | 0.12 | 0.05 | 0.12 | -0.07 |
| EBITDA | -3.35 Million | -3.35 Million | 58.57 Million | - | 32.62 Million | 3.42 Million |
| Earnings Before Tax Margin | -0.13 | -0.13 | 0.10 | 0.06 | 0.12 | -0.01 |
1618
ZFCVINDIA
5355
THEMISMED
8929
GZTGF